Nicotine Mini 4 mg/1 (Nicotine Polacrilex LOZENGE) 4 mg/1

Nicotine Mini 4 mg/1 lozenges help manage nicotine cravings for smokers looking to quit. These oral lozenges provide a 4 mg dose of nicotine polacrilex per lozenge, aiding in smoking cessation efforts.

Strength

4 mg/1

Pack Size

27 LOZENGE in 1 BOTTLE, PLASTIC (0363-0979-27)

Manufacturer / TM Owner

Walgreens

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nicotine Mini 4 mg/1 lozenges are designed to help individuals who are trying to quit smoking. They work by providing a controlled dose of nicotine, which can help reduce withdrawal symptoms and cravings. These lozenges are intended for oral use and are a part of a broader smoking cessation strategy.

Side Effects

When used as directed, Nicotine Mini 4 mg/1 lozenges can help alleviate the urge to smoke by delivering nicotine through the oral mucosa. Users may experience a reduction in cravings and withdrawal symptoms, making it easier to abstain from smoking.

Precautions & Warnings

It is important to follow the usage instructions provided with Nicotine Mini 4 mg/1 lozenges. Keep them out of reach of children and pets. Individuals with certain medical conditions or those taking other medications should consult a healthcare provider before use.

Avoid Interactions

Nicotine Mini 4 mg/1 lozenges may interact with certain medications, including those metabolized by the liver. It is advisable to avoid alcohol while using these lozenges. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Nicotine Mini 4 mg/1 lozenges are used to help manage nicotine cravings and withdrawal symptoms in individuals trying to quit smoking.

These lozenges deliver nicotine through the oral mucosa, which can help reduce the urge to smoke by providing a controlled dose of nicotine.

Individuals with certain medical conditions should consult a healthcare provider before using Nicotine Mini 4 mg/1 lozenges.

Some users may experience side effects such as nausea, headache, or mouth irritation. Always follow the usage instructions provided.

Nicotine Mini 4 mg/1 lozenges may be available for purchase online from various retailers. Check with your preferred e-commerce platform for availability.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.